https://scholars.lib.ntu.edu.tw/handle/123456789/572384
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | KAI-WEN HUANG | en_US |
dc.contributor.author | Jayant, Kumar | en_US |
dc.contributor.author | PO-HUANG LEE | en_US |
dc.contributor.author | Yang, Po-Chih | en_US |
dc.contributor.author | CHIH-YANG HSIAO | en_US |
dc.contributor.author | Habib, Nagy | en_US |
dc.contributor.author | Sodergren, Mikael H | en_US |
dc.date.accessioned | 2021-07-22T06:27:18Z | - |
dc.date.available | 2021-07-22T06:27:18Z | - |
dc.date.issued | 2019-03-19 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/572384 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) often develops on a background of chronic inflammation and a complex immunosuppressive network with increased regulatory T cells, impaired CD8⁺ T cells and the secretion of immunosuppressive cytokines. Previous clinical studies have reported a superior disease-free survival (DFS) following a radiofrequency-based ablation or resection in HCC tumours compared to conventional liver resection techniques. The aim of this study was to investigate whether there is any correlation with the use of a radiofrequency-assisted liver resection and clinical outcome. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of clinical medicine | en_US |
dc.subject | liver cancer; liver resection; radiofrequency based device | en_US |
dc.subject | Liver cancer; Liver resection; Radiofrequency based device | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | gamma interferon; interleukin 17; interleukin 1beta; interleukin 6; tumor necrosis factor; Article; blood; cancer surgery; CD4+ T lymphocyte; CD8+ T lymphocyte; cell composition; chronic inflammation; clinical outcome; disease free survival; enzyme linked immunosorbent assay; flow cytometry; histopathology; immune deficiency; immune response; immunocompetent cell; immunological parameters; immunomodulation; immunosuppressive treatment; inflammation; liver cell carcinoma; liver resection; radiofrequency; regulatory T lymphocyte; tumor growth; tumor microenvironment; tumor volume | - |
dc.title | Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.3390/jcm8030385 | - |
dc.identifier.pmid | 30893948 | - |
dc.relation.journalvolume | 8 | en_US |
dc.relation.journalissue | 3 | en_US |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Traumatology-NTUH | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.orcid | 0000-0001-6375-8714 | - |
crisitem.author.orcid | 0000-0001-5831-035X | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。